Dr. Jose Camacho, MD

NPI: 1255548327
Total Payments
$128,583
2024 Payments
$67,044
Companies
9
Transactions
174

Payment Breakdown by Category

Other$99,973 (77.7%)
Travel$21,614 (16.8%)
Food & Beverage$4,072 (3.2%)
Consulting$2,800 (2.2%)
Education$124.27 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $97,724 35 76.0%
Travel and Lodging $21,614 45 16.8%
Food and Beverage $4,072 62 3.2%
Consulting Fee $2,800 1 2.2%
Honoraria $2,250 1 1.7%
Education $124.27 30 0.1%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $121,422 120 $0 (2024)
Amgen Inc. $3,073 4 $0 (2024)
Horizon Therapeutics plc $2,361 5 $0 (2023)
Horizon Pharma plc $1,109 8 $0 (2018)
BioMarin Pharmaceutical Inc. $317.70 4 $0 (2019)
Shire North American Group Inc $175.47 3 $0 (2019)
Travere Therapeutics, Inc. $68.91 22 $0 (2023)
Ultragenyx Pharmaceutical Inc. $30.00 1 $0 (2021)
Retrophin, Inc. $25.36 7 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $67,044 47 GENZYME CORPORATION ($63,971)
2023 $32,897 39 GENZYME CORPORATION ($32,841)
2022 $5,276 16 GENZYME CORPORATION ($5,237)
2021 $9,265 11 GENZYME CORPORATION ($6,967)
2020 $3,187 13 GENZYME CORPORATION ($3,150)
2019 $7,948 25 GENZYME CORPORATION ($7,808)
2018 $1,340 12 Horizon Pharma plc ($1,109)
2017 $1,625 11 GENZYME CORPORATION ($1,378)

All Payment Transactions

174 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
11/23/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,400.00 General
Category: Genetic Disease
11/23/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $1,129.66 General
Category: Genetic Disease
11/23/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $923.96 General
Category: Genetic Disease
11/23/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $130.19 General
Category: Genetic Disease
11/23/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $126.03 General
Category: Genetic Disease
11/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,072.00 General
Category: Genetic Disease
11/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $74.52 General
Category: Genetic Disease
11/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging Cash or cash equivalent $24.82 General
Category: Genetic Disease
10/23/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $44.37 General
08/21/2024 GENZYME CORPORATION Food and Beverage In-kind items and services $38.66 General
07/10/2024 GENZYME CORPORATION XENPOZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,560.00 General
Category: Genetic Disease
07/06/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,608.00 General
Category: Genetic Disease
07/06/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $1,094.11 General
Category: Genetic Disease
07/06/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $118.26 General
Category: Genetic Disease
06/01/2024 GENZYME CORPORATION Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,120.00 General
05/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $6,656.00 General
Category: Genetic Disease
05/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $870.21 General
Category: Genetic Disease
05/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage Cash or cash equivalent $179.19 General
Category: Genetic Disease
05/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging Cash or cash equivalent $141.95 General
Category: Genetic Disease
05/09/2024 GENZYME CORPORATION FABRAZYME (Biological) Food and Beverage In-kind items and services $98.55 General
Category: Genetic Disease
05/08/2024 GENZYME CORPORATION FABRAZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,280.00 General
Category: Genetic Disease
05/08/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $917.20 General
Category: Genetic Disease
05/08/2024 GENZYME CORPORATION FABRAZYME (Biological) Travel and Lodging In-kind items and services $413.10 General
Category: Genetic Disease
04/28/2024 GENZYME CORPORATION XENPOZYME (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,792.00 General
Category: Genetic Disease
04/20/2024 GENZYME CORPORATION NEXVIAZYME (Biological), LUMIZYME Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,792.00 General
Category: Genetic Disease

About Dr. Jose Camacho, MD

Dr. Jose Camacho, MD is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255548327.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Camacho, MD has received a total of $128,583 in payments from pharmaceutical and medical device companies, with $67,044 received in 2024. These payments were reported across 174 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,724).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Clinical Genetics (M.D.)
  • Location San Francisco, CA
  • Active Since 05/17/2007
  • Last Updated 05/13/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1255548327

Products in Payments

  • FABRAZYME (Biological) $57,493
  • XENPOZYME (Biological) $43,937
  • FABRAZYME (Drug) $6,620
  • RAVICTI (Biological) $3,073
  • NO PRODUCT DISCUSSED (Drug) $2,566
  • PROCYSBI (Drug) $2,250
  • NEXVIAZYME (Biological) $1,792
  • RAVICTI (Drug) $1,147
  • LUMIZYME (Biological) $706.50
  • Vimizim (Biological) $197.74
  • VPRIV (Biological) $162.15
  • Naglazyme (Biological) $119.96
  • NO_PRODUCT (Drug) $72.99
  • DISEASE STATE (Drug) $70.00
  • (820) Cholbam (Drug) $61.90
  • Cholbam (Drug) $32.37
  • Dojolvi (Drug) $30.00
  • ELAPRASE (Biological) $13.32

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in San Francisco